We decided to focus on the AR-regulated gene, CAMKK2, which is a promising downstream target of AR and has been shown previously to affect PCa survival, metabolism, cell growth, and migration [4], It was repressed by ligand-activated ERβ (see Fig 3A). The gene discussed is ESR2; the disease is posterior cortical atrophy.